Unlocking Significant Savings for Rural Hospitals WATKINSVILLE, GA / ACCESSWIRE / January 10, 2025 / Did you know there is…
SANTA CLARA, Calif., Jan. 10, 2025 /PRNewswire/ -- Anatomage Inc., a leader in medical education technology, has announced its acquisition…
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,…
In Q1 2025, the Company will discuss the plans for NDA submission under a potential accelerated approval path for bitopertin…
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA…
Highly experienced management team with a successful track record in advancing compounds from target identification to commercialization Top-tier global investors…
New Directors Bring Extensive Leadership Experience in Corporate Strategy and CommercializationSEATTLE and VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE)…
Company Expands Reach to Government, Commercial Entities, and School Districts Amid Rising Concerns Over Spread of Respiratory Viruses such as…
Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS)…
LAVA-1266 is a potent and selective bispecific anti-CD123 Gammabody®First-in-human study enrolling adult patients with CD123-expressing AML or MDSInitial Phase 1…